Vascular impedance of uterine, inferior vesicle, and ophthalmic arteries in postmenopausal women receiving hormonal replacement therapy: Comparative Doppler study
I. Bekavac et al., Vascular impedance of uterine, inferior vesicle, and ophthalmic arteries in postmenopausal women receiving hormonal replacement therapy: Comparative Doppler study, CROAT MED J, 41(3), 2000, pp. 235-239
Aim. To investigate the effects of combined hormone replacement therapy (HR
T) on the vascular impedance of the uterine, inferior vesicle, and ophthalm
ic artery.
Methods. Thirty-five postmenopausal patients were divided in two groups: 21
patients with 1-5 years of menopause and 14 patients with greater than or
equal to 6 years of menopause. Each group was examined in basal condition a
nd after 1, 3, and 6 months of HRT. The blood flow impedances of the uterin
e, inferior vesicle, and ophthalmic arteries were analyzed by color Doppler
, Estradiol plasma concentrations were assayed on the day of Doppler examin
ation.
Results. The analysis of uterine and inferior vesicle artery flow velocitie
s showed a significant positive correlation between the resistance index (R
T) and years of menopause. Higher impedance values were found in patients w
ith longer interval from last menstrual bleeding (p <0.05). In patients wit
h greater than or equal to 6 years of menopause, the impedances of uterine
and inferior vesicle arteries were 0.94+/-0.03 and 0.91+/-0.04, respectivel
y, whereas in patients with 1-5 years of menopause the impedances were 0.89
+/-0.04 and 0.98+/-0.02, respectively. We noticed no significant correlatio
n between baseline RT and duration of menopause at the level of ophthalmic
artery in either group (0.72 vs. 0.73, respectively; p<0.05). After six mon
ths-of HRT, plasma estradiol concentrations inversely correlated with RI of
uterine (r=0.2556; p =0.021), inferior vesicle (r=0.2653; p=0.023) and oph
thalmic (r=-0.2211; p=0.017) arteries.
Conclusion. Doppler studies of uterine, inferior vesicle, and ophthalmic ar
teries can provide specific and precise pathophysiological information to a
ssess blood flow variations in correlation with combined HRT.